Treatment for Non-Alcoholic Fatty Liver Disease (NAFLD): Options, Medications & Outlook
Evidence-based Non-Alcoholic Fatty Liver Disease (NAFLD) treatment: first-line medications, monitoring targets, escalation criteria, and long-term clinical outlook.
Updated March 27, 2026
Treatment for Non-Alcoholic Fatty Liver Disease (NAFLD) focuses on inducing and maintaining clinical remission, protecting mucosal integrity, and preventing hepatic complications. NAFLD is the accumulation of fat in liver cells not caused by alcohol, affecting up to 25% of adults globally. It ranges from simple steatosis to NASH (non-alcoholic steatohepatitis), which can progress to cirrhosis; lifestyle modification is the primary treatment.
Clinical Context
The primary approach involves PPIs, aminosalicylates, corticosteroids, immunomodulators, biologics, or antiviral therapy depending on the specific condition. Monitoring typically includes endoscopy, LFTs, drug toxicity monitoring, stool calprotectin, and nutritional status. Treatment intensity is tailored to disease severity, patient comorbidities, and response. Guideline-directed therapy reduces the risk of complications, hospitalisation, and disease progression.
Clinical Pathway
Non-Alcoholic Fatty Liver Disease (NAFLD) — Full Condition GuideCondition HubNon-Alcoholic Fatty Liver Disease (NAFLD) — Treatment PathwaysTreatmentNon-Alcoholic Fatty Liver Disease (NAFLD) — Prognosis & OutlookPrognosisNon-Alcoholic Fatty Liver Disease (NAFLD) — Differential DiagnosisDifferentialFrequently Asked Questions
Treatment for Non-Alcoholic Fatty Liver Disease (NAFLD): Options, Medications & Outlook?+
Treatment for Non-Alcoholic Fatty Liver Disease (NAFLD) focuses on inducing and maintaining clinical remission, protecting mucosal integrity, and preventing hepatic complications. NAFLD is the accumulation of fat in liver cells not caused by alcohol, affecting up to 25% of adults globally. It ranges from simple steatosis to NASH (non-alcoholic steatohepatitis), which can progress to cirrhosis; lifestyle modification is the primary treatment.
What is the first-line treatment for Non-Alcoholic Fatty Liver Disease (NAFLD)?+
First-line treatment typically involves PPIs, aminosalicylates, corticosteroids, immunomodulators, biologics, or antiviral therapy depending on the specific condition. The specific agent and dose are tailored to your presentation and clinical profile.
How long does treatment for Non-Alcoholic Fatty Liver Disease (NAFLD) last?+
Some conditions require short-term treatment (acute infections, self-limiting disorders). Many chronic conditions require indefinite treatment to maintain disease control and prevent relapse.
What happens if Non-Alcoholic Fatty Liver Disease (NAFLD) is not treated?+
Untreated Non-Alcoholic Fatty Liver Disease (NAFLD) can progress, increasing the risk of complications and organ damage. Early treatment generally leads to better outcomes and reduced long-term burden.
Our AI Symptom Checker analyzes your symptoms and suggests possible conditions based on clinical guidelines.
Start Free Analysis →